Logo
x

Search

Subscribe Now

 Approval

Daiichi Sankyo and AstraZeneca Report the EC’s Approval of Enhertu for HER2 Low/Ultralow Metastatic Breast Cancer (MBC)

Daiichi Sankyo and AstraZeneca Report the EC’s Approval of Enhertu for HER2 Low/Ultralow Metastatic Breast Cancer (MBC)

  • April 4, 2025
Amgen’s Uplizna Receives the US FDA’s Approval for Immunoglobulin G4-related Disease (IgG4-RD)

Amgen’s Uplizna Receives the US FDA’s Approval for Immunoglobulin G4-related Disease (IgG4-RD)

  • April 4, 2025
Exelixis Reports the US FDA’s Approval of Cabometyx (Cabozantinib) to Treat Advanced Neuroendocrine Tumors (NETs)

Exelixis Reports the US FDA’s Approval of Cabometyx (Cabozantinib) to Treat Advanced Neuroendocrine Tumors (NETs)

  • March 27, 2025
GSK Reports the US FDA’s Approval of Blujepa (Gepotidacin) to Treat Uncomplicated Urinary Tract Infections (uUTIs)

GSK Reports the US FDA’s Approval of Blujepa (Gepotidacin) to Treat Uncomplicated Urinary Tract Infections (uUTIs)

  • March 26, 2025
China’s NMPA Approves Junshi Biosciences’ Toripalimab + Bevacizumab for Advanced Hepatocellular Carcinoma

China’s NMPA Approves Junshi Biosciences’ Toripalimab + Bevacizumab for Advanced Hepatocellular Carcinoma

  • March 24, 2025
Celltrion launches SteQeyma (Biosimilar, Stelara) in the US

Celltrion launches SteQeyma (Biosimilar, Stelara) in the US

  • March 13, 2025
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.